Advertisement
Screener

NOVAVAX INC (NVAX) ROA

NOVAVAX INC (NVAX) ROA

  • 2026-06-30: ROA -25.92%.
  • 2026-03-31: ROA -8.42%.
  • 2025-12-31: ROA 37.42%.
  • 2025-09-30: ROA 28.96%.

Complete source-backed roa history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-25.92%
2026-03-31-8.42%
2025-12-3137.42%
2025-09-3028.96%
2025-06-3031.64%
2025-03-3137.02%
2024-12-31-12.02%
2024-09-30-16.63%
2024-06-30-16.18%
2024-03-31-29.46%
2023-12-31-30.32%
2023-09-30-33.12%
2023-06-30-34.82%
2023-03-31-74.89%
2022-12-31-29.13%
2022-09-30-58.30%
2022-06-30-56.26%
2022-03-31-46.48%
2021-12-31-67.67%
2021-09-30-41.90%
2021-06-30-34.55%
2021-03-31-23.58%
2020-12-31-26.43%
2020-09-30-28.87%
2020-06-30-10.00%
2020-03-31-35.16%
2019-12-31-76.72%
2019-09-30-91.13%
2019-06-30-93.31%
2019-03-31-82.06%
2018-12-31-88.83%
2018-09-30-74.36%
2018-06-30-65.18%
2018-03-31-67.47%
2017-12-31-60.75%
2017-09-30-56.88%
2017-06-30-59.51%
2017-03-31-68.21%
2016-12-31-71.00%
2016-09-30-65.63%
2016-06-30-51.15%
2016-03-31-35.41%
2015-12-31-40.65%
2015-09-30-27.11%
2015-06-30-22.67%
2015-03-31-21.31%
2014-12-31-30.05%
2014-09-30-22.38%
2014-06-30-19.56%
2014-03-31-25.52%
2013-12-31-22.11%
2013-09-30-18.76%
2013-06-30-40.77%
2013-03-31-31.58%
2012-12-31-27.85%
2012-09-30-30.02%
2012-06-30-26.21%
2012-03-31-28.04%
2011-12-31-29.08%
2011-09-30-32.71%
2011-06-30-41.75%

Annual ROA

DateROA
2025-12-3137.42%
2024-12-31-12.02%
2023-12-31-30.32%
2022-12-31-29.13%
2021-12-31-67.67%
2020-12-31-26.43%
2019-12-31-76.72%
2018-12-31-88.83%
2017-12-31-60.75%
2016-12-31-71.00%
2015-12-31-40.65%
2014-12-31-30.05%
2013-12-31-22.11%
2012-12-31-27.85%
2011-12-31-29.09%
2010-12-31-47.71%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Vericel Corp (VCEL)United States$2.011B93.97
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16